Skip to main content

Table 3 Clinical factors potentially influencing colostomy-free survival

From: Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study

 

Univariable

Multivariable

SIB vs SeqB,

Propensity score adjusted

Endpoint

Parameter

HR

95%CI

p

HR

95%CI

p

HR

95%CI

p

CSF

SIB

0.90

0.53,1.54

0.703

1.18

0.67,2.09

0.560

1.15

0.65,2.04

0.621

SIB on the first 24 months

0.72

0.38,1.34

0.297

0.95

0.49,1.84

0.877

0.95

0.48,1.85

0.871

Sex (M vs F)

1.64

0.93,2.90

0.087

1.60

0.90,2.84

0.109

   

Age

1.02

1.00,1.04

0.119

1.02

1.00,1.04

0.124

   

Stage III vs I-II

1.78

1.03,3.05

0.037

1.83

1.04,3.22

0.037

   

G3 vs G2-G1

0.82

0.40,1.71

0.603

0.85

0.41,1.77

0.668

   

OS

SIB

1.15

0.61,2.17

0.674

1.71

0.86,3.40

0.127

1.51

0.77,2.98

0.235

Sex (M vs F)

2.64

1.38,5.07

0.003

2.77

1.43,5.37

0.003

   

Age

1.03

1.00,1.06

0.043

1.03

1.00,1.06

0.031

   

Stage III vs I-II

2.27

1.17,4.38

0.015

2.64

1.30,5.34

0.007

   

G3 vs G2-G1

1.42

0.66,3.06

0.376

1.48

0.68,3.23

0.326

   

CIC

SIB

0.71

0.34,1.47

0.352

0.87

0.41,1.85

0.713

0.85

0.39,1.83

0.675

Sex (M vs F)

0.93

0.39,2.18

0.863

0.83

0.34,2.05

0.690

   

Age

1.00

0.98,1.03

0.765

1.00

0.98,1.02

0.878

   

Stage III vs I-II

2.09

0.99,4.38

0.052

2.13

0.97,4.70

0.061

   

G3 vs G2-G1

0.44

0.13,1.48

0.184

0.43

0.13,1.45

0.173

   
  1. Legend HR hazard ratio CI confidence interval, M vs F male vs female, UFS colostomy-free survival, OS Overall Survival, CIC Cumulative Incidence of colostomy